RESTRUCTURING AND OTHER SPECIAL CHARGES

3 Months Ended

Sep. 30, 2020

Restructuring and Related Activities [Abstract]

Restructuring and Related Activities Disclosure [Text Block]

RESTRUCTURING AND OTHER CHARGES

During the nine months ended September 30, 2020, the Company recorded net restructuring and other charges of $38.9: $13.4 within LCD and $25.5 within CDD. The charges were comprised of $12.8 related to severance and other personnel costs, $11.0 for a CDD leased lab facility and equipment impairments, and $24.0 in facility closures, impairment of operating lease right-of use assets and general integration activities. The charges were offset by the reversal of previously established liability of $1.1 and $7.8 in unused severance costs and facility-related costs, respectively.

During the nine months ended September 30, 2019, the Company recorded net restructuring and other charges of $48.4: $22.8 within LCD and $25.6 within CDD. The charges were comprised of $26.2 related to severance and other personnel costs and $22.0 in costs associated with facility closures, impairment of operating lease right-of-use assets and general integration initiatives. The charges were increased by the adjustment of previously established reserves of $0.4 in severance reserves and decreased by a reversal of $0.2 in unused facility reserves.

The following represents the Company’s restructuring reserve activities for the period indicated:

	LCD				CDD
	Severance and Other Employee Costs		Facility Costs		Severance and Other Employee Costs		Facility Costs		Total
Balance as of December 31, 2019	$	0.5	$	2.7	$	5.5	$	4.7	$	13.4
Restructuring charges	3.9		5.2		8.9		6.7		24.7
Impairment of lab facility and equipment	—		5.8		—		17.3		23.1
Cash payments and other adjustments	(4.4)		(12.2)		(10.4)		(23.8)		(50.8)
Balance as of September 30, 2020	$	—	$	1.5	$	4.0	$	4.9	$	10.4
Current									$	8.1
Non-current									2.3
									$	10.4